BMRN
BioMarin Pharmaceutical Inc. · Healthcare · Biotechnology
Señales de momentum (gestores comparables):
amplitud de titulares +5.0% ·
flujo de acciones +2.3% ·
nuevas posiciones netas +4.8%
· fórmula
Acumulación amplia: acciones en aumento entre más titulares
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q4 2024
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 1.42M | $84.45M | n/a | −2 |
| Q2 2026 | 135 | +4 | 146.70M | $8.39B | +11 | −8 |
| Q1 2026 | 135 | -4 | 142.18M | $8.03B | +5 | −10 |
| Q4 2025 | 138 | +3 | 154.93M | $9.20B | +4 | n/a |
| Q3 2025 | 23 | -1 | 108.93M | $5.90B | n/a | −2 |
| Q2 2025 | 22 | -2 | 113.78M | $6.25B | n/a | −2 |
| Q1 2025 | 21 | 0 | 70.58M | $4.99B | +1 | −1 |
| Q4 2024 | 21 | +1 | 67.83M | $4.46B | +1 | n/a |
| Q3 2024 | 19 | 0 | 57.19M | $4.02B | +2 | −2 |
| Q2 2024 | 19 | n/a | 53.80M | $4.43B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | PRIMECAP Management ✦ | 18.19M | -3.6% | $1.20B | 0.9% | ▼ Trim | 3 | SEC ↗ |
| 2 | Dodge & Cox ✦ | 14.75M | +6.1% | $969.27M | 0.6% | ▲ Add | 3 | SEC ↗ |
| 3 | Viking Global Investors ✦ | 10.51M | +7.8% | $690.86M | 2.2% | ▲ Add | 3 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (pasivo) | 9.11M | n/a | $598.94M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Norges Bank ✦ (pasivo) | 3.57M | +1.0% | $234.64M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | Elliott Investment Management ✦ | 3.50M | 0.0% | $230.08M | 2.5% | Held | 3 | SEC ↗ |
| 7 | Geode Capital Management ✦ (pasivo) | 3.29M | +0.9% | $215.78M | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 8 | AQR Capital Management ✦ | 1.28M | +114.5% | $84.37M | 0.1% | ▲ Add | 3 | SEC ↗ ×5 |
| 9 | Marshall Wace ✦ | 680.59K | Nuevo | $44.74M | 0.1% | New | 1 | SEC ↗ ×2 |
| 10 | T. Rowe Price ✦ | 592.39K | -10.7% | $38.94M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 11 | Renaissance Technologies ✦ | 435.87K | +4.1% | $28.65M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Millennium Management ✦ | 408.16K | -36.5% | $26.83M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 387.61K | -67.8% | $25.48M | 0.0% | ▼ Trim | 3 | SEC ↗ ×2 |
| 14 | Bridgewater Associates ✦ | 302.48K | +112.5% | $19.88M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 15 | D. E. Shaw & Co. ✦ | 275.45K | +68.6% | $18.11M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 16 | Point72 Asset Management ✦ | 266.44K | +34.8% | $17.51M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | Two Sigma Investments ✦ | 232.81K | -22.3% | $15.30M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | Fisher Asset Management ✦ | 13.97K | +3.1% | $918,007 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 19 | Gotham Asset Management ✦ | 11.73K | -49.8% | $771,276 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 20 | GAMCO Investors ✦ | 10.04K | +52.9% | $659,929 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 21 | Wellington Management ✦ | 7.46K | +5.7% | $490,412 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Marshall Wace | $44.74M | 0.1% |
Posición cerrada
| Sin salidas rastreadas este trimestre. |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 549 tenedores, 183.01M acciones, $10.09B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 17.56K acc. · $1.16M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología